| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
|
Lau, George
|
|
|
18 |
6 |
p. 1661-1683
|
artikel
|
| 2 |
Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLD
|
Jiang, Mingqian
|
|
|
18 |
6 |
p. 1731-1739
|
artikel
|
| 3 |
Dynamic role of exosomal long non-coding RNA in liver diseases: pathogenesis and diagnostic aspects
|
Ismail, Mohammed
|
|
|
18 |
6 |
p. 1715-1730
|
artikel
|
| 4 |
Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapy
|
Lai, Kuan-Chang
|
|
|
18 |
6 |
p. 1804-1814
|
artikel
|
| 5 |
Identification of PANoptosis-relevant subgroups and predicting signature to evaluate the prognosis and immune landscape of patients with biliary tract cancer
|
Liu, Dongming
|
|
|
18 |
6 |
p. 1792-1803
|
artikel
|
| 6 |
Incidence, risk factors, and outcomes of acute liver injury in hospitalized adults with acute kidney injury: a large multicenter study
|
Lin, Yuxin
|
|
|
18 |
6 |
p. 1756-1769
|
artikel
|
| 7 |
Is laparoscopic hepatectomy superior to radiofrequency ablation in treating small hepatocellular carcinoma?
|
Xiong, Dali
|
|
|
18 |
6 |
p. 1815-1816
|
artikel
|
| 8 |
Letter to the editor to ‘‘Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases’’
|
Yao, Bihua
|
|
|
18 |
6 |
p. 1817-1818
|
artikel
|
| 9 |
Management and treatment of severe immune-related hepatotoxicity based on clinical and pathological characteristics
|
Zhang, Nan
|
|
|
18 |
6 |
p. 1770-1780
|
artikel
|
| 10 |
Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog/SMO signaling
|
Zong, Ruobin
|
|
|
18 |
6 |
p. 1781-1791
|
artikel
|
| 11 |
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
|
Suoh, Maito
|
|
|
18 |
6 |
p. 1740-1755
|
artikel
|
| 12 |
Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management
|
Shukla, Akash
|
|
|
18 |
6 |
p. 1684-1711
|
artikel
|
| 13 |
Rechallenge with immune checkpoint inhibitors therapy for patients with HCC-lot more to learn
|
Lau, George
|
|
|
18 |
6 |
p. 1712-1714
|
artikel
|
| 14 |
Who better identifies significant liver fibrosis, MAFLD or MASLD, needs more rigorous, in-depth study
|
Zou, Haoxuan
|
|
|
18 |
6 |
p. 1819-1820
|
artikel
|
Tijdschrift beschrijving